Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nicolas Roche (Paris, France), Nicolas Roche, Caroline Laurendeau, Chantal Raherison, Claire Fuhrman, Pierre-Régis Burgel. Modeling future COPD epidemiology. Eur Respir J 2016; 48: Suppl. 60, 3115

Member's Comments

No comment yet.

Related content which might interest you: Current and future costs of COPD in the Netherlands Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Predicting risk of undiagnosed COPD in primary care: Development and validation of the TargetCOPD model Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016 A systematic review of models of COPD epidemiology Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Unemployment in COPD: Results from the BOLD study Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Current and future costs of asthma in the Netherlands Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Estimating severe asthma prevalence in austria using nationwide prescription data Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 COPD guideline adherence in hospital- and population-recruited COPD patients Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Understanding inequalities in COPD prevention and care policies across Europe Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Death risk factors in COPD patients in Italian general practices: The COMODHES study Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 Assessment of public awareness on COPD in Singapore in a one-day awareness campaign Source: International Congress 2016 – Public health related concerns and epidemiology of smoking and smoking-related products Year: 2016 The burden of chronic obstructive pulmonary disease (COPD) in Taiwan Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Validation of the COPD lung cancer screening score in a community based cohort of COPD patients Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Does NICE COPD audit tools affect management of COPD? Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 COPD over diagnosis in the UK Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 COPD morbidity screening in high risk groups Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Digital Therapy in the treatment of asthma and COPD - Epidemiology of development and use of an emerging health technology in Respiratory Medicine Source: International Congress 2019 – M-health/e-health II Year: 2019 Inequalities on medical diagnosis and underdiagnosis of COPD: The PLATINO study Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Decision analytic models in COPD/asthma: A critical review of current evidence Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016 Healthcare utilization and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Analysis of the quality of rehabilitation in disabled due to COPD in Ukraine Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016